Samantha McLemore - Patient Capital Management Holdings – 2026 Q1
Explore the latest portfolio disclosure for Samantha McLemore - Patient Capital Management, with insights into sector exposure, position sizes, and overall investment structure for 2026 Q1.
The latest 2026 Q1 filing shows that Samantha McLemore - Patient Capital Management maintains its largest exposure in Unclassified Sector, which represents approximately 22.01% of the portfolio. This sector forms the core of Samantha McLemore - Patient Capital Management's investment stance during this reporting period.
Additional major allocations include Technology (about 18.72%) and Healthcare (approximately 17.92%) , reflecting how Samantha McLemore - Patient Capital Management diversifies beyond its primary sector focus.
These sector weightings provide a clear view into Samantha McLemore - Patient Capital Management's positioning and conviction areas for the 2026 Q1 quarter.
Breakdown by Sector
| Symbol | Shares | Reported Price(USD) | Action | Change % | Portfolio Weight | Position Value | Filing Period |
|---|---|---|---|---|---|---|---|
| RPRX | 3,643,716 | $47.97 | Increased | 9.30% | 6.52% | $174.79M | 2026 Q1 |
| C | 1,413,870 | $113.41 | Increased | 9.45% | 5.98% | $160.35M | 2026 Q1 |
| GOOGL | 533,993 | $287.56 | Reduced | -8.19% | 5.73% | $153.56M | 2026 Q1 |
| AMZN | 654,419 | $208.27 | Increased | 16.33% | 5.09% | $136.3M | 2026 Q1 |
| QXO | 6,778,389 | $19.42 | Increased | 4.79% | 4.91% | $131.64M | 2026 Q1 |
| NVDA | 711,115 | $174.4 | Increased | 11.32% | 4.63% | $124.02M | 2026 Q1 |
| UNH | 437,141 | $270.59 | Increased | 18.69% | 4.41% | $118.29M | 2026 Q1 |
| ET | 6,088,203 | $19.3 | Increased | 15.46% | 4.38% | $117.5M | 2026 Q1 |
| IAC | 2,699,564 | $40.03 | Increased | 13.71% | 4.03% | $108.06M | 2026 Q1 |
| NCLH | 5,749,640 | $18.7 | Increased | 8.32% | 4.01% | $107.52M | 2026 Q1 |
| SDRL | 2,152,685 | $45.5 | Increased | 4.81% | 3.65% | $97.95M | 2026 Q1 |
| META | 171,086 | $572.13 | Increased | 19.56% | 3.65% | $97.88M | 2026 Q1 |
| CVS | 1,357,159 | $71.82 | Increased | 10.21% | 3.64% | $97.47M | 2026 Q1 |
| COIN | 430,405 | $174.61 | Increased | 140.55% | 2.80% | $75.15M | 2026 Q1 |
| ADBE | 297,279 | $243.08 | Buy | 100.00% | 2.70% | $72.26M | 2026 Q1 |
| CROX | 842,842 | $83.02 | Increased | 11.08% | 2.61% | $69.97M | 2026 Q1 |
| BIIB | 379,741 | $183.33 | Reduced | -34.11% | 2.60% | $69.62M | 2026 Q1 |
| PGEN | 17,817,387 | $3.87 | Reduced | -4.58% | 2.57% | $68.95M | 2026 Q1 |
| UAL | 732,020 | $92.07 | Increased | 11.91% | 2.51% | $67.4M | 2026 Q1 |
| ILMN | 544,780 | $123.26 | Reduced | -5.38% | 2.51% | $67.15M | 2026 Q1 |
| NE | 1,347,854 | $49.07 | Increased | 5.21% | 2.47% | $66.14M | 2026 Q1 |
| GM | 744,630 | $74.5 | Reduced | -3.50% | 2.07% | $55.47M | 2026 Q1 |
| FISV | 968,194 | $55.8 | Increased | 273.59% | 2.02% | $54.03M | 2026 Q1 |
| CHYM | 2,882,016 | $18.73 | Increased | 41.61% | 2.01% | $53.98M | 2026 Q1 |
| UBS | 1,241,955 | $39.07 | Increased | 4.60% | 1.81% | $48.52M | 2026 Q1 |